Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Invita AG
Tech Transfer Roundup: Neon Licenses NKI IP To Advance Cell Therapy Into Clinic
Continuing a partnership between Neon co-founder and two Netherlands Cancer Institute researchers, agreement will help autologous T-cell candidate move into Phase I. Plus Scrip's monthly roundup of tech transfer deals.
Recent Tech Transfer Deals, October 2014
Derived from Strategic Transactions, a premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced August through September 2014.
Life Science Start-Ups: Tech Transfer Deals, May 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Tech Transfers column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2014.
Deals Update
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- AMAREG
- allegropharm GmbH
- Haupt Pharma
- hci-healthcare invest GmbH
- PH-Pharma Holding AG
- Wülfing Pharma GmbH (formerly SmithKline Beecham Pharma, Ltd), MVB Beteiligungen AG
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice